Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses

• Li-Xin Wang ,

  Contributed equally to this work with: Li-Xin Wang, Zhen-Yang Mei

  Affiliations Department of Hematology, Chinese PLA General Hospital, Beijing, China, Department of Hematology, Navy General Hospital, Beijing, China, Department of Pathology and Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio, United States of America

  ⨯
• Zhen-Yang Mei ,

  Contributed equally to this work with: Li-Xin Wang, Zhen-Yang Mei

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Ji-Hao Zhou,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Yu-Shi Yao,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Yong-Hui Li,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Yi-Han Xu,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Jing-Xin Li,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Xiao-Ning Gao,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Min-Hang Zhou,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Meng-Meng Jiang,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Li Gao,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Yi Ding,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Xue-Chun Lu,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Jin-Long Shi,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Xu-Feng Luo,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Jia Wang,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Li-Li Wang,

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Chunfeng Qu,

  Affiliation State Key Laboratory of Molecular Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Beijing, China

  ⨯
• Xue-Feng Bai ,

  * E-mail: chunhuiliyu@yahoo.com (LY); Xue-Feng.Bai@osumc.edu (XFB)

  Affiliation Department of Pathology and Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio, United States of America

  ⨯
•  [ ... ],
• Li Yu

  * E-mail: chunhuiliyu@yahoo.com (LY); Xue-Feng.Bai@osumc.edu (XFB)

  Affiliation Department of Hematology, Chinese PLA General Hospital, Beijing, China

  ⨯
• [ view all ]
• [ view less ]